Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance

Immunology and Cell Biology

Volumn 77, Issue 3, 1999, Pages 216-223

  Pender, Michael P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; Autoimmunity; CD95 (Fas); Experimental autoimmune encephalomyelitis; Immune tolerance; T lymphocyte; Transplantation

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; APOPTOSIS; CONFERENCE PAPER; IMMUNOLOGICAL TOLERANCE; LIVER TRANSPLANTATION; NONHUMAN; RAT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET ORGAN;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 0033013092     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00818.x     Document Type: Conference Paper

References (82)

1. 1 Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 1998; 19: 395-404.
2. 2 Wekerle H, Linington C, Lassmann H, Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci. 1986; 9: 271-7.
3. 3 Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 1991; 28: 254-60.
4. 4 Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 1998; 280: 243-8.
5. 5 Pender MP, McCombe PA, Yoong G, Nguyen KB. Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance. J Autoimmun. 1992; 5: 401-10.
6. 6 Pender MP. Apoptosis in the target organ of an autoimmune disease. In: Lavin M, Watters D (eds). Programmed Cell Death: The Cellular and Molecular Biology of Apoptosis. Chur: Harwood Academic Publishers, 1993; 235-44.
7. 7 Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989; 337: 181-4.
8. 8 Russell JH, White CL, Loh DY, Meleedy-Rey P. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl Acad. Sci. USA 1991; 88: 2151-5.
9. 9 Alderson MR, Tough TW, Davis-Smith T et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995; 181: 71-7.
10. 10 Brunner T, Mogil RJ, LaFace D et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373: 441-4.
11. 11 Dhein J, Walczak H, Bäumler C, Debatin K-M, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995; 373: 438-41.
12. 12 Ju S-T, Panka DJ, Cui H et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444-8.
13. 13 Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998; 281: 1305-8.
14. 14 Scaffidi C, Fulda S, Srinivasan A et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998; 17: 1675-87.
15. 15 Strasser A, Harris AW, Huang DCS, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 1995; 14: 6136-47.
16. 16 Li H, Zhu H, Xu C-J, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
17. 17 Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochrondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-90.
18. 18 Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 1993; 151: 621-7.
19. 19 Lee RK, Spielman J, Podack ER. bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis. Int. Immunol. 1996; 8: 991-1000.
20. L. Immunity 1995; 3: 87-98.
21. 21 Liu Y, Janeway CA. Interferon γ plays a critical role in induced cell death of effector T cell: A possible third mechanism of self-tolerance. J. Exp. Med. 1990; 172: 1735-9.
22. 22 Groux H, Monte D, Plouvier B, Capron A, Ameisen J-C. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: Respective roles of interleukin-1, interleukin-2, interferon-γ and accessory cells. Eur. J. Immunol. 1993; 23: 1623-9.
23. 23 Collette Y, Razanajaona D, Ghiotto M, Olive D. CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism. Eur. J. Immunol. 1997; 27: 3283-9.
24. 24 Schweitzer AN, Sharpe AH. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J. Immunol. 1998; 161: 2762-71.
25. 25 Deng G, Podack ER. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc. Natl Acad. Sci. USA 1993; 90: 2189-93.
26. + helper T cells: A model for the long-term survival of memory cells. J. Immunol. 1996; 156: 1764-71.
27. 27 Ford AL, Foulcher E, Lemekert FA, Sedgwick JD. Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 1996; 184: 1737-45.
28. 28 Ahmed R, Gray D. Immunological memory and protective immunity: Understanding their relation. Science 1996; 272: 54-60.
29. 29 Lenardo MJ. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 1991; 353: 858-61.
30. 30 Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998; 8: 615-23.
31. 31 Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994; 12: 991-1045.
32. 32 Pender MP. Experimental autoimmune encephalomyelitis. In: Pender MP, McCombe PA (eds). Autoimmune Neurological Disease. Cambridge: Cambridge University Press, 1995; 26-88.
33. 33 Pender MP, Nguyen KB, McCombe PA, Kerr JFR. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 1991; 104: 81-7.
34. 34 Schmied M, Breitschopf H, Gold R et al. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 1993; 143: 446-52.
35. + encephalitogenic T cells. Eur. J. Immunol. 1994; 24: 2609-17.
36. + T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J. Neurol. Sci. 1996; 139: 1-6.
37. 37 Tabi Z, McCombe PA, Pender MP. Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: Further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. Int. Immunol. 1995; 7: 967-73.
38. 38 Bauer J, Bradl M, Hickey WF et al. T-cell apoptosis in inflammatory brain lesions: Destruction of T cells does not depend on antigen recognition. Am. J. Pathol. 1998; 153: 715-24.
39. 39 Ohmori K, Hong Y, Fujiwara M, Matsumoto Y. In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis: Evidence suggesting that most infiltrating T cells do not proliferate in the target organ. Lab. Invest. 1992; 66: 54-62.
40. 40 Nguyen KB, McCombe PA, Pender MP. Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Autoimmun. 1994; 7: 145-52.
41. 41 Nguyen KB, McCombe PA, Pender MP. Increased apoptosis of T lymphocytes and macrophages in the central and peripheral nervous systems of Lewis rats with experimental autoimmune encephalomyelitis treated with dexamethasone. J. Neuropathol. Exp. Neurol. 1997; 56: 58-69.
42. 42 White CA, McCombe PA, Pender MP. Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95). Int. Immunol. 1998; 10: 935-41.
43. + cells. J. Neuroimmunol. 1996; 70: 93-101.
44. 44 Zacharchuk CM, Merćep M, Chakraborti PK, Simons SS, Ashwell JD. Programmed T lymphocyte death: Cell activation-and steroid-induced pathways are mutually antagonistic. J. Immunol. 1990; 145: 4037-45.
45. 45 Yang Y, Merćep M, Ware CF, Ashwell JD. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 1995; 181: 1673-82.
46. 46 White CA, McCombe PA, Pender MP. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1998; 82: 47-55.
47. 47 Ishigami T, White CA, Pender MP. Soluble antigen therapy induces apoptosis of autoreactive T cells preferentially in the target organ rather than in the peripheral lymphoid organs. Eur. J. Immunol. 1998; 28: 1626-35.
48. 48 Matsumoto Y, Ohmori K, Fujiwara M. Immune regulation by brain cells in the central nervous system: Microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology 1992; 76: 209-16.
49. 49 Gold R, Schmied M, Tontsch U et al. Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death: A model for T-cell apoptosis in vivo. Brain 1996; 119: 651-9.
50. 50 Kohji T, Tanuma N, Aikawa Y et al. Interaction between apoptotic cells and reactive brain cells in the central nervous system of rats with autoimmune encephalomyelitis. J. Neuroimmunol. 1998; 82: 168-74.
51. 51 Matsumoto Y, Hara N, Tanaka R, Fujiwara M. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology. J. Immunol. 1986; 136: 3668-76.
52. 52 MacPhee IAM, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 1989; 169: 431-45.
53. 53 Smith T, Schmied M, Hewson AK, Lassmann H, Cuzner ML. Apoptosis of T cells and macrophages in the central nervous system of intact and adrenalectomized Lewis rats during experimental allergic encephalomyelitis. J. Autoimmun. 1996; 9: 167-74.
54. 54 Qian S, Lu L, Fu F et al. Apoptosis within spontaneously accepted mouse liver allografts: Evidence for deletion of cytotoxic T cells and implications for tolerance induction. J. Immunol. 1997; 158: 4654-61.
55. 55 Willenborg DO. Experimental allergic encephalomyelitis in the Lewis rat: Studies on the mechanism of recovery from disease and acquired resistance to reinduction. J. Immunol. 1979; 123: 1145-50.
56. 56 Levine S, Hoenig EM, Wenk EJ. Altered distribution of lesions after repeated passive transfers of allergic encephalomyelitis. Proc. Soc. Exp. Biol. Med. 1967; 126: 454-8.
57. 57 Levine S, Sowinski R. Experimental allergic encephalomyelitis: Inhibition of clinical signs and paradoxical enhancement of lesions in second attacks. Am. J. Pathol. 1980; 101: 375-86.
58. 58 Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 1995; 32: 121-82.
59. 59 Pender MP. Multiple sclerosis. In: Pender MP, McCombe PA (eds). Autoimmune Neurological Disease. Cambridge: Cambridge University Press, 1995; 89-154.
60. 60 Ozawa K, Suchanek G, Breitschopf H et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994; 117: 1311-22.
61. 61 Dowling P, Husar W, Menonna J, Donnenfeld H, Cook S, Sidhu M. Cell death and birth in multiple sclerosis brain. J. Neurol. Sci. 1997; 149: 1-11.
62. 62 Charriaut-Marlangue C, Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport 1995; 7: 61-4.
63. 63 Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology 1995; 21: 1465-8.
64. 64 Pender MP. Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis. Lancet 1998; 351: 978-81.
65. 65 Zettl UK, Gold R, Hartung H-P, Toyka KV. Apoptotic cell death of T-lymphocytes in experimental autoimmune neuritis of the Lewis rat. Neurosci. Lett. 1994; 176: 75-9.
66. 66 Zettl UK, Gold R, Toyka KV, Hartung H-P. In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat. Acta Neuropathol. 1996; 91: 360-7.
67. 67 Weishaupt A, Gold R, Gaupp S, Giegerich G, Hartung H-P, Toyka KV. Antigen therapy eliminates T cell inflammation by apoptosis: Effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2. Proc. Natl Acad. Sci. USA 1997; 94: 1338-43.
68. 68 Zettl UK, Gold R, Toyka KV, Hartung H-P. Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat. J. Neuropathol. Exp. Neurol. 1995; 54: 540-7.
69. b in the liver. Eur. J. Immunol. 1995; 25: 1932-42.
70. + T lymphocytes but fail lo promote survival. Eur. J. Immunol. 1998; 28: 221-36.
71. 71 Kurts C, Heath WR, Carbone FR, Allison J, Miller JFAP, Kosaka H. Constitutive class T-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 1996; 184: 923-30.
72. 72 Bishop GA, Sun J, Sheil AGR, McCaughan GW. High-dose/ activation-associated tolerance: A mechanism for allograft tolerance. Transplantation 1997; 64: 1377-82.
73. 73 Sun J, Sheil AGR, Wang C et al. Tolerance to rat liver allografts. IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation 1996; 62: 1725-30.
74. 74 Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-92.
75. 75 Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630-2.
76. 76 Allison J, Georgiou HM, Strasser A, Vaux DL. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl Acad. Sci. USA 1997; 94: 3943-7.
77. 77 Lou Y-H, McElveen F, Adams S, Tung KSK. Altered target organ: A mechanism of postrecovery resistance to murine autoimmune oophoritis. J. Immunol. 1995; 155: 3667-73.
78. 78 Kong L, Ogawa N, Nakabayashi T et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 1997; 40: 87-97.
79. 79 Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J. Clin. Invest. 1995; 96: 1631-8.
80. 80 Nakajima T, Aono H, Hasunuma T et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 1995; 38: 485-91.
81. 81 Barac-Latas V, Wege H, Lassmann H. Apoptosis of T lymphocytes in coronavirus-induced encephalomyelitis. Regional Immunol. 1994; 6: 355-7.
82. + T cells and rapid elimination of effector cells by apoptosis. Eur. J. Immunol. 1998; 28: 3448-55.